Biogen Idec hires from Novartis to head ALS
September 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns
Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …
Janssen: why transparency is essential to the health of our industry
August 29, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency
The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …
Publish all clinical trials, say pharma doctors
August 29, 2014Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency
All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …
Amgen submits next gen cholesterol drug
August 29, 2014Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins
Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …
MSC hires new president and chief executive
August 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mary Beth Loesch, msc
US healthcare performance firm Medical Simulation Corporation has confirmed the appointment of Mary Beth Loesch as its president and chief executive. Loesch …
GSK Ebola vaccine fast-tracked into human trials
August 28, 2014Sales and Marketing Africa, Ebola, GSK, WHO, zmapp
GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …
Government rips up blank cheque on cancer drugs
August 28, 2014Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi
Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …
Biostar appoints chief scientist
August 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xiaohui Zheng, biostar pharmaceuticals
Chinese manufacturing and marketing firm Biostar Pharmaceuticals has hired professor Xiaohui Zheng as its chief scientist.Zheng is a professor and director of …
Ice Bucket Challenge nears $100m in donations
August 28, 2014Medical Communications, Research and Development, Sales and Marketing Clovis Pharma, Motor Neurone Disease Association
Charitable donations to a once obscure healthcare charity called the ALS Association have rocketed in August after its #IceBucketChallenge went …
NICE final ‘yes’ for Biogen’s MS pill
August 27, 2014Sales and Marketing Aubagio, Biogen, RMS, RRMS, gilenya
In final guidance published today NICE has recommended NHS funding of Biogen Idec’s new multiple sclerosis pill in patients with …
Merck Serono breaks ground in China with new plant
August 27, 2014Manufacturing and Production, Sales and Marketing China, Merck Serono, manufacturing, metformin
Merck Serono has broken ground for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be …
US rivals Pfizer and Merck team up for lung cancer
August 27, 2014Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab
The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …
UK nurse with Ebola given new drug in London
August 27, 2014Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp
A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …
Miriam Monge to join Sartorius Stedim Biotech
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Sartorius Stedim Biotech (SSB), a pharma and biotech supplier, today announced the appointment of Miriam Monge as director of marketing …
AstraZeneca and Illumina in new partnership
August 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing
AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …
AZ launches US digital tool ‘DoctorsNotes’ in US
August 26, 2014Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital
AstraZeneca has launched a new online tool in the US called DoctorsNotes to help medical professionals keep better up to …
Merck and Advaxis team up on immuno-oncology
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab
Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …
Asterias Biotherapeutics adds two to board
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer
US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …
NICE and market access: time for reform?
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform
Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …
Roche pays $8.3bn for InterMune
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche
Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
